EWTXEdgewise Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15062
Ticker: EWTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-03-26
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: EWTX

Detail

Enriched 2026-08-14 20:47

Market cap: $4,730,795,859.24
Shares outstanding (class): 108,604,129
Shares outstanding (weighted): 108,604,129
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 127
Location: BOULDER, CO
Homepage: https://www.edgewisetx.com
Description: Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Market cap and share counts drift.

Funds holding this security

105 funds · 109 positions · $388.85M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$90.23M	0.00%	2,864,296 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$51.99M	0.07%	1,650,589 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$26.02M	0.03%	826,170 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$20.77M	0.40%	659,507 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$18.02M	0.22%	572,192 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$17.38M	0.14%	551,740 NS	FIGI
abrdn Healthcare Investors —	—	$14.90M	1.31%	472,983 NS	FIGI
Driehaus Small Cap Growth Fund Driehaus Mutual Funds	—	$14.84M	1.29%	471,229 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$14.61M	0.28%	463,699 NS	FIGI
abrdn Life Sciences Investors —	—	$11.12M	1.98%	353,076 NS	FIGI
Artisan International Small-Mid Fund Artisan Partners Funds Inc.	—	$10.36M	0.39%	328,745 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$9.48M	0.31%	301,061 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$6.52M	0.65%	207,131 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$6.00M	1.95%	190,497 NS	FIGI
Driehaus Micro Cap Growth Fund Driehaus Mutual Funds	—	$5.89M	1.29%	186,995 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEREWTX
FIGI_COMPOSITEBBG00K4Y2H24
FIGI_SHARE_CLASSBBG00K4Y2H33
CIK0001710072
ISINUS28036F1057
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm as indicated by its SIC code and common stock instrument type.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.